Actos News
Takeda to Buy Amgen Japan Unit for Up to $902 Million (Update2) - Bloomberg
all 60 news articles
Takeda 3rd-Qtr Net Gains 5.9% on Actos Diabetes Pill (Update1) - Bloomberg
Actos sales jumped 14 percent to 106 billion yen, spurred by a May 21 report linking GlaxoSmithKline Plc's Avandia, its main competitor, to a higher heart ...
Japan's Takeda posts record profit on brisk drug sales, weak yen - Forbes
The company said global sales of its diabetes treatment drug piglitazone, known in Japan as Actos, rose 23.3 percent to 312.7 billion yen. ...
Takeda Nine-Month Net Jumps 25% on Actos Pill Sales (Update1) - Bloomberg
... Pharmaceutical Co., Japan's largest drugmaker, reported a 25 percent jump in nine-month profit, helped by sales of its best-selling Actos diabetes pill. ...
Takeda 9-month profit up 25 pct on Actos sales - Reuters
Sales of Actos, the main earnings engine for Takeda, have risen while those for GlaxoSmithKline's (GSK.L: Quote, Profile, Research) Avandia have tumbled ...
Takeda's Third-Quarter Profit Jumps 5.9% on Actos Diabetes Drug - Bloomberg
Actos overtook GlaxoSmithKline Plc's Avandia as the world's top-selling diabetes medicine after the Glaxo drug was linked in a May 21 report to a higher ...
UPDATE: Takeda, Daiichi Sankyo Report Oct-Dec Profit Growth - Therapeutics Daily (subscription) (press release)
TO) said Thursday its net profit rose 25% in the April-December period, supported by continued sales growth of its diabetes drug Actos and the blood ...
Takeda 9-month profit up 25 pct on Actos sales - Reuters
Sales of Actos, the main earnings engine for Takeda, have risen while those for GlaxoSmithKline's (GSK.L: Quote, Profile, Research) Avandia have tumbled ...
Why Belly Fat Hurts the Heart - WebMD
After visceral fat transplantation, mice developed less severe atherosclerosis if their chow was laced with the diabetes drug Actos for 10 weeks. ...
GSK’s Avandia sees strengthened warning; EMEA - Pharma Times (subscription)
The changes have been recommended in the wake of an overall safety reassessment of both Avandia and Eli Lilly/Takeda’s Actos (pioglitazone), which concluded ...
Actos RSS Feed